Relapsed/Refractory B-cell Lymphoma Clinical Trials

11 clinical trials for Relapsed/Refractory B-cell Lymphoma across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Study Evaluating ISM8207 in Participants With Advanced Solid Tumors and Relapsed/Refractory B-Cell Lymphoma — RECRUITING · PHASE1
• Efficacy and Safety of CD19/CD20 CAR/TRuC-T in Relapsed/Refractory B-Cell Lymphoma — RECRUITING · PHASE1
• Efficacy and Safety of CD19CD20-CAR.p40-T in B-cell Lymphoma — RECRUITING · PHASE1
• RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas — NOT_YET_RECRUITING · PHASE1
• Nanobody-Based CD19/CD20 Tandem Dual CAR-T-cell Therapy of Relapsed/Refractory B-Cell Lymphoma — NOT_YET_RECRUITING · PHASE1
• Phase I Clinical Study on the Safety and Efficacy of CY-219 CAR-T Cell Injection in the Treatment of Relapsed/Refractory B-Cell Lymphoma — NOT_YET_RECRUITING · PHASE1
• RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas — NOT_YET_RECRUITING · PHASE1
• A Clinical Study of of RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas — NOT_YET_RECRUITING · PHASE1
• FT522 With Rituximab in Relapsed/Refractory B-Cell Lymphoma (FT522-101) — COMPLETED · PHASE1
• A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in R/R ALL and Lymphoma Subjects — OTHER · PHASE1
• A Phase IB Study Of The BTKi CC-292 Combined With Lenalidomide In Adults Patients With Relapsed/Refractory B-Cell Lymphoma — COMPLETED · PHASE1

Refine this search